JM Interna s.r.o.

Clinical research at JM Interna s.r.o. focuses on cardiovascular diseases, especially atherosclerotic cardiovascular disease and elevated lipoprotein(a). The studies are designed to assess whether new therapies can reduce the risk of major heart and blood vessel complications and improve long-term outcomes for patients.

• Testing approaches for atherosclerotic cardiovascular disease and related risk reduction
• Evaluating treatment benefit in people with elevated lp(a)
• Measuring the ability of new therapies to lower serious cardiovascular event rates

This work reflects a strong interest in preventing events such as heart attack, stroke, and urgent coronary procedures, with the goal of improving protection for patients at higher cardiovascular risk.

The site also supports trials in nutritional and metabolic diseases, with a clear emphasis on obesity and overweight. Research here is exploring whether new treatment options can support weight-related health improvement while also lowering the chance of serious complications linked to excess body weight.

• Studying new therapy options for obesity management
• Assessing outcomes in adults living with overweight
• Examining whether treatment can also help protect kidney function and reduce cardiovascular risk

The research at this hospital/clinic setting links metabolic health with broader organ protection, highlighting interest in both heart-related and kidney-related benefits.